Detalhe da pesquisa
1.
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
Invest New Drugs
; 40(1): 134-141, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463891
2.
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial.
JAMA Oncol
; 5(6): 824-830, 2019 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30998813